Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2018

01-10-2018 | Letter to the Editor

Evaluation of IVD 3.0 Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium tuberculosis and nontuberculous mycobacteria and its use in routine diagnostics

Authors: Elio Cenci, Eugenio Luciano, Marika Bucaioni, Monica Rubeca, Angelica Cesarini, Silvia Bozza, Giuseppe Vittorio De Socio, Antonella Mencacci

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2018

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Springer B, Stockman L, Teschner K, Roberts GD, Böttger EC (1996) Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods. J Clin Microbiol 34:296–303PubMedPubMedCentral
2.
Wattal C, Oberoi JK, Goel N, Raveendran R, Khanna S (2017) Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) for rapid identification of micro-organisms in the routine clinical microbiology laboratory. Eur J Clin Microbiol Infect Dis 36(5):807–812CrossRefPubMed
3.
Clark AE, Kaleta EJ, Arora A, Wolk DM (2013) Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin Microbiol Rev 26:547–603CrossRefPubMedPubMedCentral
4.
Buckwalter SP, Olson SL, Connelly BJ, Lucas BC, Rodning AA, Walchak RC, Deml SM, Wohlfiel SL, Wengenack NL (2016) Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium species, Nocardia species, and other aerobic actinomycetes. J Clin Microbiol 54(2):376–384CrossRefPubMedPubMedCentral
5.
Rodríguez-Sánchez B, Ruiz-Serrano MJ, Marín M, López Roa P, Rodríguez-Créixems M, Bouza E (2015) Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of non-tuberculous mycobacteria from clinical isolates. J Clin Microbiol 53(8):2737–2740CrossRefPubMedPubMedCentral
6.
Neuschlova M, Vladarova M, Kompanikova J, Sadlonova V, Novakova E (2017) Identification of Mycobacterium species by MALDI-TOF mass spectrometry. Adv Exp Med Biol 1021:37–42CrossRefPubMed
7.
Leyer C, Gregorowicz G, Mougari F, Raskine L, Cambau E, de Briel D (2017) Comparison of Saramis 4.12 and IVD 3.0 Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of mycobacteria from solid and liquid culture media. J Clin Microbiol 55(7):2045–2054CrossRefPubMedPubMedCentral
8.
Body BA, Beard MA, Slechta ES, Hanson KE, Barker AP, Babady NE, McMillen T, Tang YW, Brown-Elliott BA, Iakhiaeva E, Vasireddy R, Vasireddy S, Smith T, Wallace RJ Jr, Turner S, Curtis L, Butler-Wu S, Rychert J (2018) Evaluation of the Vitek MS v3.0 matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Mycobacterium and Nocardia species. J Clin Microbiol. 56(6). https://​doi.​org/​10.​1128/​JCM.​00237-18
9.
10.
García-Agudo L, Jesús I, Rodríguez-Iglesias M, García-Martos P (2011) Evaluation of INNO-LiPA mycobacteria v2 assay for identification of rapidly growing mycobacteria. Braz J Microbiol 42(3):1220–1226CrossRefPubMedPubMedCentral
11.
Padilla E, González V, Manterola M, Pérez A, Quesada MD, Gordillo S, Vilaplana C, Pallarés MA, Molinos S, Sánchez MD, Ausina V (2004) Comparative evaluation of the new version of the INNO-LiPA mycobacteria and GenoType Mycobacterium assays for the identification of Mycobacterium species from MB/BacT liquid cultures artificially inoculated with mycobacterial strains. J Clin Microbiol 42:3083–3088CrossRefPubMedPubMedCentral
12.
Tortoli E, Mariottini A, Mazzarelli G (2003) Evaluation of INNO-LiPA mycobacteria v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification. J Clin Microbiol 41:4418–4420CrossRefPubMedPubMedCentral
13.
Lawn SD, Nicol MP (2011) Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol 6:1067–1082CrossRefPubMedPubMedCentral
14.
Tortoli E, Rindi L, Garcia MJ, Chiaradonna P, Dei R, Garzelli C, Kroppenstedt RM, Lari N, Mattei R, Mariottini A, Mazzarelli G, Murcia MI, Nanetti A, Piccoli P, Scarparo C (2014) Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. Int J Syst Evol Microbiol 54(Pt 4):1277–1285
15.
Fattorini L, Mustazzolu A, Borroni E, Piccaro G, Giannoni F, Cirillo DM, Italian Multicentre Study on Resistance to Antituberculosis Drugs (SMIRA) Group (2016) Tuberculosis in migrants from 106 countries to Italy, 2008–2014. Eur Respir J 47(4):1273–1276CrossRefPubMed
16.
Park IK, Olivier KN (2015) Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis. Semin Respir Crit Care Med 36(2):217–224CrossRefPubMed
Metadata
Title
Evaluation of IVD 3.0 Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium tuberculosis and nontuberculous mycobacteria and its use in routine diagnostics
Authors
Elio Cenci
Eugenio Luciano
Marika Bucaioni
Monica Rubeca
Angelica Cesarini
Silvia Bozza
Giuseppe Vittorio De Socio
Antonella Mencacci
Publication date
01-10-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3326-3

Other articles of this Issue 10/2018

European Journal of Clinical Microbiology & Infectious Diseases 10/2018 Go to the issue

Original Article

Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-series

Review

Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches

Original Article

Molecular epidemiology of virulence and antimicrobial resistance determinants in Klebsiella pneumoniae from hospitalised patients in Kilimanjaro, Tanzania

Original Article

Clonal diversity of Ureaplasma species and its relationship with oligozoospermia and semen quality in Chinese infertile males

Original Article

Incidence and predictors of intravenous acyclovir-induced nephrotoxicity

Review

Genetic approach towards a vaccine against malaria
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits